Yuanwei Zang

520 total citations
21 papers, 375 citations indexed

About

Yuanwei Zang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yuanwei Zang has authored 21 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Yuanwei Zang's work include RNA modifications and cancer (3 papers), Cancer Research and Treatments (2 papers) and Cancer Mechanisms and Therapy (2 papers). Yuanwei Zang is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer Research and Treatments (2 papers) and Cancer Mechanisms and Therapy (2 papers). Yuanwei Zang collaborates with scholars based in China and United States. Yuanwei Zang's co-authors include Zhonghua Xu, Liang Fang, Juchao Ren, Yongzhen Zhang, Yong‐Zhen Zhang, Jingxin Li, Yongxiang Li, Zeyan Li, Yan Li and Wenjun Ni and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Yuanwei Zang

19 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanwei Zang China 12 197 115 71 70 49 21 375
Alysia Kern Lovgren United States 6 171 0.9× 93 0.8× 137 1.9× 84 1.2× 30 0.6× 6 501
Samina Dongol China 14 266 1.4× 202 1.8× 38 0.5× 98 1.4× 52 1.1× 17 463
Jiming Bao China 9 228 1.2× 78 0.7× 53 0.7× 49 0.7× 19 0.4× 22 373
Tetsuhiro Horie Japan 14 282 1.4× 85 0.7× 31 0.4× 132 1.9× 28 0.6× 37 459
Yanghe Zhang China 9 215 1.1× 151 1.3× 43 0.6× 40 0.6× 18 0.4× 16 385
Pia Sulas Italy 12 242 1.2× 132 1.1× 26 0.4× 51 0.7× 17 0.3× 15 464
Lawrence N. Barrera United Kingdom 12 215 1.1× 83 0.7× 13 0.2× 80 1.1× 46 0.9× 13 386
Jeanine Traag United States 4 222 1.1× 69 0.6× 27 0.4× 93 1.3× 23 0.5× 4 356
Jarosław Szefel Poland 12 123 0.6× 65 0.6× 83 1.2× 133 1.9× 30 0.6× 25 374
Shulin Wu China 6 343 1.7× 103 0.9× 41 0.6× 40 0.6× 17 0.3× 10 484

Countries citing papers authored by Yuanwei Zang

Since Specialization
Citations

This map shows the geographic impact of Yuanwei Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanwei Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanwei Zang more than expected).

Fields of papers citing papers by Yuanwei Zang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanwei Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanwei Zang. The network helps show where Yuanwei Zang may publish in the future.

Co-authorship network of co-authors of Yuanwei Zang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanwei Zang. A scholar is included among the top collaborators of Yuanwei Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanwei Zang. Yuanwei Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Zenghui, Yuqiong Wang, Chao Zheng, et al.. (2025). NAT10 promotes the progression of clear cell renal cell carcinoma by regulating ac4C acetylation of NFE2L3 and activating AKT/GSK3β signaling pathway. Cell Death and Disease. 16(1). 235–235. 3 indexed citations
2.
Yan, Hao, Xinyu Cai, Jianna Zhang, et al.. (2024). Gastric cancer cell-derived exosomal miRNA-128-3p promotes angiogenesis by targeting SASH1. Frontiers in Oncology. 14. 1440996–1440996.
3.
4.
Zhang, Chen, et al.. (2022). Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma. Frontiers in Genetics. 13. 970900–970900. 2 indexed citations
5.
Zang, Yuanwei, Birgit Ehmer, Jun‐Lin Guan, et al.. (2021). Selective MAP1LC3C (LC3C) autophagy requires noncanonical regulators and the C-terminal peptide. The Journal of Cell Biology. 220(7). 9 indexed citations
6.
Li, Yongxiang, Liang Qiao, Yuanwei Zang, Wenjun Ni, & Zhonghua Xu. (2020). <p>Circular RNA FOXO3 Suppresses Bladder Cancer Progression and Metastasis by Regulating MiR-9-5p/TGFBR2</p>. Cancer Management and Research. Volume 12. 5049–5056. 38 indexed citations
7.
Xu, Jianing, Neil D. Gross, Yuanwei Zang, et al.. (2019). Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma. Molecular Diagnosis & Therapy. 23(3). 407–417. 5 indexed citations
8.
Fang, Liang, Yongzhen Zhang, Qi Wang, et al.. (2019). A polysaccharide from Huaier ameliorates cisplatin nephrotoxicity by decreasing oxidative stress and apoptosis via PI3K/AKT signaling. International Journal of Biological Macromolecules. 139. 932–943. 45 indexed citations
9.
Fang, Liang, Yong‐Zhen Zhang, Yuanwei Zang, et al.. (2019). HP-1 inhibits the progression of ccRCC and enhances sunitinib therapeutic effects by suppressing EMT. Carbohydrate Polymers. 223. 115109–115109. 25 indexed citations
10.
11.
Zhang, Yong‐Zhen, Liang Fang, Yuanwei Zang, Juchao Ren, & Zhonghua Xu. (2018). CIP2A Promotes Proliferation, Invasion and Chemoresistance to Cisplatin in Renal Cell Carcinoma. Journal of Cancer. 9(21). 4029–4038. 22 indexed citations
12.
Zhao, Fen, et al.. (2018). End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 144(8). 1591–1599. 9 indexed citations
13.
Zang, Yuanwei, Fen Zhao, Zhenxiang Li, et al.. (2017). Inhibition of HIF-1α by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo.. PubMed. 7(5). 1198–1212. 43 indexed citations
14.
Yang, Feilong, Di Yu, Yong‐Zhen Zhang, et al.. (2017). Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia. BioMed Research International. 2017. 1–8. 6 indexed citations
15.
Zang, Yuanwei, Xiang Zhang, Lei Yan, et al.. (2017). Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma. Journal of Cancer. 8(15). 3049–3061. 30 indexed citations
16.
Zang, Yuanwei, et al.. (2017). Inhibition of hypoxia-inducible factor-1α by PX-478 as a potential targeted therapy in ESCC.. Journal of Clinical Oncology. 35(15_suppl). e14083–e14083. 1 indexed citations
17.
Zhang, Xiang, Juchao Ren, Lei Yan, et al.. (2015). Cytoplasmic Expression of Pontin in Renal Cell Carcinoma Correlates with Tumor Invasion, Metastasis and Patients’ Survival. PLoS ONE. 10(3). e0118659–e0118659. 21 indexed citations
18.
Zhang, Xiang, Lei Yan, Wei Jiao, et al.. (2015). The clinical and biological significance of MICA in clear cell renal cell carcinoma patients. Tumor Biology. 37(2). 2153–2159. 14 indexed citations
19.
Li, Yan, et al.. (2012). H2S Relaxes Vas Deferens Smooth Muscle by Modulating the Large Conductance Ca2+-Activated K+ (BKCa) Channels via a Redox Mechanism. The Journal of Sexual Medicine. 9(11). 2806–2813. 30 indexed citations
20.
Li, Jingxin, Yan Li, Yahui Du, et al.. (2010). Endogenous hydrogen sulfide as a mediator of vas deferens smooth muscle relaxation. Fertility and Sterility. 95(5). 1833–1835. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alysia Kern Lovgren Breakdown of academic impact, for papers by Samina Dongol Breakdown of academic impact, for papers by Jiming Bao Breakdown of academic impact, for papers by Tetsuhiro Horie Breakdown of academic impact, for papers by Yanghe Zhang Breakdown of academic impact, for papers by Pia Sulas Breakdown of academic impact, for papers by Lawrence N. Barrera Breakdown of academic impact, for papers by Jeanine Traag Breakdown of academic impact, for papers by Jarosław Szefel Breakdown of academic impact, for papers by Shulin Wu
Rankless by CCL
2026